{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:04:20Z","timestamp":1789646660247,"version":"4.0.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.micpath.2022.105568","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T02:00:39Z","timestamp":1652061639000},"page":"105568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Interferon inducible guanylate binding protein 1 restricts the growth of Leishmania donovani by modulating the level of cytokines\/chemokines and MAP kinases"],"prefix":"10.1016","volume":"168","author":[{"given":"Ravindra","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6186-0456","authenticated-orcid":false,"given":"Pramod Kumar","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2022.105568_bib2","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.4049\/jimmunol.154.10.5320","article-title":"IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis","volume":"154","author":"Scharton-Kersten","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib3","series-title":"Immunobiology of Leishmaniasis","author":"Sharma","year":"2009"},{"key":"10.1016\/j.micpath.2022.105568_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0167-5699(94)90176-7","article-title":"Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection","volume":"15","author":"Reiner","year":"1994","journal-title":"Immunol. today"},{"key":"10.1016\/j.micpath.2022.105568_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.imbio.2007.12.005","article-title":"The innate immune response against Leishmania parasites","volume":"213","author":"Liese","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.micpath.2022.105568_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.189.4.741","article-title":"Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani","volume":"189","author":"Murray","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2022.105568_bib7","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.4049\/jimmunol.176.9.5519","article-title":"Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen","volume":"176","author":"Perez","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1189\/jlb.0904546","article-title":"Slc11a1\u2010mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activity","volume":"77","author":"White","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.micpath.2022.105568_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.det.2010.08.014","article-title":"Innate immunity and Leishmania vaccination strategies","volume":"29","author":"Birnbaum","year":"2011","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.micpath.2022.105568_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fimmu.2014.00296","article-title":"Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects","volume":"5","author":"Singh","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001148","article-title":"Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63","volume":"6","author":"Contreras","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2022.105568_bib13","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.micpath.2022.105568_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fimmu.2017.00849","article-title":"Leishmania amazonensis-induced cAMP triggered by adenosine A2B receptor is important to inhibit dendritic cell activation and evade immune response in infected mice","volume":"8","author":"Figueiredo","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1462-5822.2006.00769.x","article-title":"Leishmania promastigotes activate PI3K\/Akt signalling to confer host cell resistance to apoptosis","volume":"9","author":"Ruhland","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.micpath.2022.105568_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1017\/S0031182013002187","article-title":"Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4","volume":"141","author":"Rojas-Bernabe","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2022.105568_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0169-4758(98)01362-3","article-title":"How do protozoan parasites survive inside macrophages?","volume":"15","author":"Bogdan","year":"1999","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.micpath.2022.105568_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fimmu.2013.00156","article-title":"Interferon gamma in leishmaniasis","volume":"4","author":"Kima","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/eji.1830270409","article-title":"Interleukin\u201010 and interleukin\u20104 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation","volume":"27","author":"Vouldoukis","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-3024.2002.00444.x","article-title":"Arginase I induction in macrophages, triggered by Th2\u2010type cytokines, supports the growth of intracellular Leishmania parasites","volume":"24","author":"Iniesta","year":"2002","journal-title":"Parasite immun."},{"key":"10.1016\/j.micpath.2022.105568_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-\u03b3","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.imbio.2007.09.018","article-title":"Emerging themes in IFN-\u03b3-induced macrophage immunity by the p47 and p65 GTPase families","volume":"212","author":"Shenoy","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.micpath.2022.105568_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.185.7.1231","article-title":"Intracellular antimicrobial activity in the absence of interferon-\u03b3: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-\u03b3 gene-disrupted mice","volume":"185","author":"Taylor","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2022.105568_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1126\/science.1201711","article-title":"A family of IFN-\u03b3\u2013inducible 65-kD GTPases protects against bacterial infection","volume":"332","author":"Kim","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.micpath.2022.105568_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/jir.2007.0086","article-title":"Unique features of different members of the human guanylate-binding protein family","volume":"27","author":"Tripal","year":"2007","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micpath.2022.105568_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1189\/jlb.4MR0516-223R","article-title":"Interferon-inducible guanylate-binding proteins at the interface of cell-autonomous immunity and inflammasome activation","volume":"101","author":"Man","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.micpath.2022.105568_bib27","doi-asserted-by":"crossref","first-page":"15834","DOI":"10.1016\/S0021-9258(17)36334-2","article-title":"Affinity purification of an interferon-induced human guanylate-binding protein and its characterization","volume":"260","author":"Cheng","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2022.105568_bib28","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.4049\/jimmunol.2100325","article-title":"Tupaia GBP1 interacts with STING to initiate autophagy and restrict herpes simplex virus type 1 infection","volume":"207","author":"Gu","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104926","article-title":"Direct binding of polymeric GBP1 to LPS disrupts bacterial cell envelope functions","volume":"39","author":"Kutsch","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.micpath.2022.105568_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16889-z","article-title":"Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria","volume":"11","author":"Santos","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2022.105568_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01464-20","article-title":"Guanylate binding proteins restrict Leishmania donovani growth in nonphagocytic cells independent of parasitophorous vacuolar targeting","volume":"11","author":"Haldar","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2022.105568_bib32","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1073\/pnas.1619665114","article-title":"Guanylate-binding protein 1 (GBP1) contributes to the immunity of human mesenchymal stromal cells against Toxoplasma gondii","volume":"114","author":"Qin","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.micpath.2022.105568_bib33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.vaccine.2004.06.054","article-title":"Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis","volume":"23","author":"Garg","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2022.105568_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00436-005-1339-1","article-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models","volume":"96","author":"Dube","year":"2005","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2022.105568_bib35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jlb.59.4.555","article-title":"Differences in the state of differentiation of THP\u20101 cells induced by phorbol ester and 1, 25\u2010dihydroxyvitamin D3","volume":"59","author":"Schwende","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.micpath.2022.105568_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002551","article-title":"Sleeping with the enemy: how intracellular pathogens cope with a macrophage lifestyle","volume":"8","author":"Thi","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2022.105568_bib37","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/IAI.70.9.5026-5035.2002","article-title":"Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages","volume":"70","author":"Junghae","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2022.105568_bib38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0140-6736(18)33057-5","article-title":"Leishmaniasis\u2013authors' reply","volume":"393","author":"Burza","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2022.105568_bib39","first-page":"238","article-title":"Immune response to Leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.micpath.2022.105568_bib40","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.4049\/jimmunol.179.11.7729","article-title":"Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense","volume":"179","author":"Degrandi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-9-292","article-title":"Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus","volume":"9","author":"Pan","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2022.105568_bib42","first-page":"2021","article-title":"A chimera of Th1 stimulatory proteins of Leishmania donovani offers moderate immunotherapeutic efficacy with a Th1-inclined immune response against visceral leishmaniasis","author":"Ratnapriya","year":"2021","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2022.105568_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0952-7915(91)90079-G","article-title":"Role of nitric oxide synthesis in macrophage antimicrobial activity","volume":"3","author":"Nathan","year":"1991","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pim.12071","article-title":"To investigate the therapeutic potential of immunochemotherapy with cisplatin+ 78 k D a+ MPL\u2010A against L eishmania donovani in BALB\/c mice","volume":"36","author":"Joshi","year":"2014","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fimmu.2012.00069","article-title":"Vaccines for canine leishmaniasis","volume":"3","author":"Palatnik-de-Sousa","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2022.105568_bib46","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1096\/fj.13-245126","article-title":"Role of protein kinase R in the killing of Leishmania major by macrophages in response to neutrophil elastase and TLR4 via TNF\u03b1 and IFN\u03b2","volume":"28","author":"Faria","year":"2014","journal-title":"Faseb. J."},{"key":"10.1016\/j.micpath.2022.105568_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.09-140053","article-title":"Novel role for the double\u2010stranded RNA\u2010activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania","volume":"24","author":"Pereira","year":"2010","journal-title":"Faseb. J."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:48:02Z","timestamp":1760111282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401022001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":46,"alternative-id":["S0882401022001814"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105568","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon inducible guanylate binding protein 1 restricts the growth of Leishmania donovani by modulating the level of cytokines\/chemokines and MAP kinases","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105568"}}